Baseline data | P | OR (95% CI) |
---|---|---|
group | 0.041* | 1.965 (1.026–3.761) |
Male (n, %) | 0.036* | 2.212 (1.005–4.639) |
Age (years) | 0.079 | 0.977 (0.952–1.003) |
Combined therapy (n, %) | 0.177 | 0.647 (0.344–1.271) |
BMI (kg/m2) | 0.272 | 0.937 (0.834–1.052) |
WBC (×109/L) | 0.352 | 0.919 (0.770–1.098) |
NE% | 0.285 | 0.189 (0.009–3.999) |
NE (×109/L) | 0.157 | 0.846 (0.671–1.067) |
RBC (×1012/L) | 0.671 | 0.886 (0.508–1.547) |
HB (g/L) | 0.603 | 1.005 (0.985–1.026) |
RDW (%) | 0.240 | 0.837 (0.622–1.126) |
PLT (×109/L) | 0.955 | 1.000 (0.955–1.004) |
PT (s) | 0.065 | 1.362 (0.981–1.890) |
PTA (%) | 0.004* | 0.959 (0.932–0.987) |
INR | 0.732 | 1.505 (0.145–15.615) |
F (g/L) | 0.643 | 0.918 (0.638–1.321) |
APTT (s) | 0.546 | 1.020 (0.957–1.086) |
APTTR | 0.216 | 3.879 (0.452–33.267) |
TT (s) | 0.648 | 1.051 (0.848–1.303) |
TTR | 0.694 | 1.925 (0.074–50.085) |
TB (umol/L) | 0.873 | 0.999 (0.991–1.007) |
DBIL (umol/L) | 0.891 | 0.999 (0.990–1.009) |
TP (g/L) | 0.450 | 0.982 (0.937–1.029) |
A (g/L) | 0.370 | 0.975 (0.920–1.031) |
ALT (U/L) | 0.000* | 1.003 (1.002–1.003) |
AST (U/L) | 0.000* | 1.004 (1.002–1.006) |
ALP (U/L) | 0.507 | 1.004 (0.991–1.018) |
r-GT (U/L) | 0.135 | 1.005 (0.998–1.011) |
FBG (mmol/L) | 0.896 | 0.986 (0.801–1.214) |
BUN (mmol/L) | 0.441 | 0.904 (0.700–1.168) |
CR (mmol/L) | 0.014* | 0.970 (0.946–0.994) |
UA (umol/L) | 0.635 | 1.001 (0.998–1.004) |
TC (mmol/L) | 0.088 | 0.790 (0.602–1.036) |
TG (mmol/L) | 0.250 | 0.780 (0.511–1.191) |
HDL-C (mmol/L) | 0.769 | 1.161 (0.428–3.153) |
LDL-C (mmol/L) | 0.022* | 0.668 (0.473–0.944) |
HBsAg S/CO | 0.979 | 1.000 (1.000–1.000) |
HBeAg S/CO | 0.945 | 1.000 (0.999–1.001) |
HBV DNA Log10IU/mL | 0.061 | 0.774 (0.592–1.012) |